Jakarta, 29 May 2023 Through our Community-Led Monitoring (CLM) of Viral Hepatitis services, we found that since 2019 there have been several stockouts of Hepatitis C medicines. The most current one is the stock-out of Daclatasvir since early April 2023. Today, Peduli Hati Bangsa together with other community organizations carry out an action to ask…
Category: HepC-en
Peduli Hati Bangsa, together with the Clinton Health Access Initiative (CHAI) had the opportunity to have a discussion with the National Narcotics Agency (BNN). We were received by: In 2021 WHO reported that the number of HBV has reached 296 million and HCV around 58 million, with 23-39% of the total new HCV cases being…
On 27-28 April 2023, Peduli Hati Bangsa had the opportunity to take part in Access to emerging medications for the prevention and treatment of hepatitis B and HIV consultation meeting organized by TREAT Asia/amfAR in Bangkok. The aim of this meeting was to review morbidity and mortality data specifically in the Hepatitis B region in…
Hotel Mercure Batavia, Mei 2023 HIV, Hepatitis B, and Hepatitis C have similar modes of transmission. Due to the similar transmission mode, people with HIV must also have information and knowledge about Hepatitis B and C. With this in mind, we are collaborating with the Pelita Ilmu Foundation in an in-house training activitiy to strengthen…
by Caroline Thomas 12 April 2023 Today we had the opportunity to be part of the team for development of standards for communicable disease, especially HIV-TB, at the Technical Implementation Units for Correctional Facilities. Why is it important for us to be involved in HIV and TB issues? Despite the fact that most of the…